claim
In individuals with depression who exhibited elevated inflammatory markers, specifically C-reactive protein (CRP) and tumor necrosis factor-alpha (TNF-α), treatment with the TNF-α antagonist infliximab led to improvements in depressive symptoms.

Authors

Sources

Referenced by nodes (1)